DIN 02499967 — DUOBRII 0.045 %; 0.01 %
DUOBRII is a lotion of Halobetasol Propionate / Tazarotene marketed by BAUSCH HEALTH, CANADA INC.. The full Halobetasol Propionate / Tazarotene monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02499967
- Brand name
- DUOBRII
- Active ingredient
- Halobetasol Propionate / Tazarotene
- Strength
- 0.045 %; 0.01 %
- Dosage form
- LOTION
- Route
- TOPICAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Topical antipsoriatic combination (superpotent corticosteroid + retinoid)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.